Navigation Links
AMPAC Fine Chemicals Continues to Invest in Quality Systems
Date:2/14/2012

RANCHO CORDOVA, Calif., Feb. 14, 2012 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a wholly owned subsidiary of American Pacific Corporation (Nasdaq: APFC), reports that it has joined Rx-360 as an active member.  Rx-360 is a pharmaceutical and biotech industry consortium that was founded by industry leaders to enhance the security of the pharmaceutical supply chain and to assure the quality and authenticity of the products moving through the supply chain.  AFC is contributing to the Rx-360's joint audit pilot program as the first U.S.-based active pharmaceutical ingredient (API) manufacturer to be audited.

AFC's ongoing focus and commitment to quality has resulted in a successful U.S. Food and Drug Administration (FDA) pre-approval inspection (PAI) for seven oncology and anti-viral products, subsequently resulting in FDA approval for several of these products.  This is the latest of several successful inspections at the AFC Rancho Cordova, California, facility over the past year, including a combined FDA PAI and general inspection, and inspections by the Korean FDA (KFDA) and the European Medicines Agency (EMA).

"We continue to invest in our quality systems and this is demonstrated by our successful inspections by the FDA, KFDA and EMA.  In 2011, we were also re-accredited by the Japanese PMDA," stated Jeff Robinson, Vice President of Quality and Regulatory Affairs.  "With our recent inspections and active participation in Rx-360's audit program, we continue to validate our commitment to quality and transparency."

"Successful audits by various regulatory agencies coupled with AFC joining Rx-360 substantiates our commitment to Quality and to AFC's Continuous Improvement Initiative," stated Aslam Malik, President AMPAC Fine Chemicals.

ABOUT Rx-360
Rx-360 was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain.  The mission of the new organization is timely in light of growing attacks and threats to an increasingly complex and global supply chain.  Millions of people around the world are treated every day with the vital medicines that pharmaceutical and biotechnology companies provide.  Management of the pharmaceutical supply chain has become one of the top public health concerns with respect to consumer safety.  The globalization of distribution for both drug components and finished products has introduced many complications that Rx-360 is positioned to help resolve.  To learn more about Rx-360 go to the Rx-360 website at www.Rx-360.org.

ABOUT AMPAC FINE CHEMICALS LLC
AFC is a U.S.-based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients (API's) and registered intermediates for pharmaceutical and biotechnology customers.  Its specially engineered facilities and experienced staff allow AFC to safely produce highly energetic compounds at commercial scale.  In addition, AFC's other technology platforms include production of highly potent compounds, continuous processes and industrial-scale chromatographic separation using simulated moving bed chromatography (SMB).  AFC's operations are located in Rancho Cordova, CA and in La Porte, Texas.  Additional information about us can be obtained by visiting our web site at www.ampacfinechemicals.com.

ABOUT AMERICAN PACIFIC CORPORATION
American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets.  We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry.  For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications.  We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry.  Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals.  Additional information about us can be obtained by visiting our web site at www.apfc.com.Technical Contact:

William DuBay, Ph.D., Vice President, 

Technology and Business Development 

AMPAC Fine Chemicals 

+1 (800) 311-9668 

+1 (916) 357-6880 

 Investor Contact:

Deanna Riccardi 

American Pacific Corporation 

+1 (702) 735-2200


'/>"/>
SOURCE American Pacific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AMPAC Fine Chemicals Completes Contract Manufacturing Agreement for Smallpox Countermeasure API
2. AMPAC Fine Chemicals Validates Continuous Extraction Process for API Manufacture
3. AMPAC Fine Chemicals Announces the Inauguration of the New cGMP Continuous Processing Development Facility
4. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
5. Bio architecture lab technology converts seaweed to renewable fuels and chemicals
6. Reportlinker Adds Global Immunochemicals Industry
7. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
8. Agrivida Announces Collaboration With Syngenta Ventures to Deliver Low-Cost Sugars for Cellulosic Biofuels and Biochemicals
9. Chemicals study pinpoints threat to workers lungs
10. AloeSafe™ Hand Sanitizer is Free From Toxic Chemicals
11. 21st Century Biochemicals Marks Its Third Consecutive Year on the Inc. 5000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , ... May 04, 2016 , ... PBI-Gordon Corporation is ... Agricultural Sales. , Doug began his career at PBI-Gordon in February 1988, after ... a wide variety of roles, ranging from customer service to national product manager, to ...
(Date:5/3/2016)... 2016 The report "Biochips ... Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), ... Centers), Fabrication Technology (Microarrays, Microfluidics) - Forecast ... is expected to reach USD 17.75 Billion ... 2015, growing at a CAGR of 18.4% ...
(Date:5/3/2016)... ... ... In a list published by the Boston Business Journal, iLab Solutions ... percentage of the state's 615,000+ small businesses. The list examined companies based in the ... to 2015. , As this award comes on the heels of iLab’s ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... of Dr. Nancy Gillett to its Board of Directors. Dr. Gillett recently retired ... Corporate Executive Vice President and Chief Scientific Officer. A board-certified veterinary pathologist, Dr. ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/18/2016)... , March 18, 2016 ... Suppliers of Biometrics, ICT, Manned & Unmanned Vehicles, Physical infrastructure ... & security companies in the border security market and the ... and Europe has led visiongain ... companies improved success. --> defence & security ...
Breaking Biology News(10 mins):